Entecavir Overview Categories No Categories Defined Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Entecavir Manufacturers of Entecavir Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Entecavir's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 1 to 1 mg1 (1)24 hourlyPOFor amivudin refrectory or known lamivudine or telbivodine resistance mutations. Decompensated liver disease0.5 to 0.5 mg0.5 (0.5)24 hourlyPOOnce daily Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Entecavir is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Entecavir is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Glimepiride Back to top Manufacturers of Entecavir in Pakistan Amson Atco Biogen Bosch Brookes Caraway CCL Cirin Danas Dyson R L Fassgen Ferozson GENE-TECH LABS Genome Global Goodman L GSK Highnoon Linear Macter Mass Navegal Neo Nimrall Novamed Ocean Olive Labs Panacea Prays Rotex S.J.& G Selmore Shaigan Shawan Swan Well Welmark WnsFeild Xenon Back to top Previous Drug Generic - Next Drug Generic